Abstract
Background: There is conflicting evidence for the benefit of adjuvant chemotherapy following resection of distal cholangiocarcinoma (dCCA), especially for node-negative (N0) resections. We aimed to evaluate the association of adjuvant chemotherapy with survival after surgical resection of dCCA.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: HPB : the official journal of the International Hepato Pancreato Biliary Association
Paper Title
Journal
Date
